drugset / Trial / NCT01294215

High Dose BAYA1040_Nifedipine: a Long Term Combination Study

NCT01294215

Phase 3 Completed 72 enrolled Bayer
Non-randomizedSingle-groupOpen-labelTreatment

Summary

This is a clinical study evaluating the safety and efficacy of long term administration of oral BAYA1040\_Nifedipine 80 mg/day (40 mg twice daily) with other antihypertensives in patients with essential hypertension who are not at target blood pressure by the combination of BAYA1040\_Nifedipine 40 mg once daily and other antihypertensives.

Timeline

Start
2011-02
Primary completion
2011-11
Completion
2012-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Nifedipine Other / unclassified 40 mg Oral

Indications